Quoin Pharmaceuticals, Ltd. Profile Avatar - Palmy Investing

Quoin Pharmaceuticals, Ltd.

Quoin Pharmaceuticals, Ltd., a specialty pharmaceutical company, focuses on the development of therapeutic products for rare and orphan diseases. The company's lead product is QRX003, a topical lotion to treat Netherton Syndrome. It also develops QRX004 …

Biotechnology
US, Ashburn [HQ]

Risk Factors

By Management
Not Available

    No Risk Factor available yet. You can request "Risk Factors" through an email.

End of QNRX's Analysis
CIK: - CUSIP: 74907L102 ISIN: US74907L3006 LEI: - UEI: -
Secondary Listings
QNRX has no secondary listings inside our databases.